LaparotomyNCT03966768
DuraMesh Laparotomy Study
A study testing Duramesh suturable mesh for laparotomy closure and Conventional suture for laparotomy closure in people with Laparotomy and Suture; Complications, Mechanical, run by Mesh Suture Inc..
Trial summary
This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Laparotomy, Suture; Complications, Mechanical, Hernia Incisional
- What is being tested?
- Duramesh suturable mesh for laparotomy closure and Conventional suture for laparotomy closure
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 15 Oct 2023to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Midline laparotomy greater than 5 cm in length
- Urgent or emergent surgery following trauma
- Urgent or emergent surgery for diverticulitis
- Large or small bowel obstruction, acute abdomen, or intra-abdominal hemorrhage.
- Open abdomen after midline laparotomy.
Who cannot join
- Prior hernia repair or existing abdominal mesh
- Metastatic cancer
- Pregnancy
- Immunosuppression.
About this study
Official title: DuraMesh Laparotomy Closure Following Trauma and Emergency Surgery
This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. One hundred (100) patients will be randomized (2:1) to Duramesh laparotomy closure versus conventional suture closure.
After the patient has been confirmed to be a candidate for the trial, randomization will be performed in the operating room upon completion of the index abdominal procedure. Duramesh will be provided for patients assigned to the Duramesh treatment arm. Patients will be followed for 1 year following laparotomy closure at follow-up intervals of 1 month, 3 months, 6 months, and 12 months.
Read the detailed description
Primary Laparotomy Closure Treatment 1) Study Group - Duramesh Laparotomy Closure (DLC) Treatment 2) Control Group - Conventional Suture Closure (CSC)
Patients undergoing a midline laparotomy for trauma or emergency surgery will have their abdominal wall laparotomy incision closed with size 0 Duramesh suturable mesh. Patients randomized to conventional laparotomy closure will be closed using size
1 slowly-absorbing (PDS) single strand or looped suture, based on surgeon preference.
While it would be preferable to identify a single conventional suture to serve as the control group, polling of potential participating surgeons demonstrated a preference for both single strand and looped sutures to be available for use in the conventional suture closure group. Both Duramesh and conventional sutures will be placed using a standardized closure technique that incorporates 1cm wide bites and 1cm spacing, as this is the established technique for trauma and emergency laparotomy closure at both participating institutions. An effort to quantify suture to wound length ratio will be made in an effort to confirm standardization of closure technique between groups. The small-bites surgical closure technique popular in Europe has not been adopted by trauma and emergency surgeons at either institution given concerns related to early dehiscence and the inability to extrapolate the STITCH trial data to a US trauma population. The surgeons at both institutions do not believe it acceptable to generalize the European trial with a mean BMI of 24 to the United States population, nor do they believe it wise to close the abdominal wall with a 2-0 polydioxanone suture, as this technique trended towards a higher rate of acute fascial dehiscence (burst abdomen).
All patients will be assessed for post-operative complications ( i . e . , infection, seroma, hematoma), a t 1 , 3 , 6 , and 12 months p o s t o p e r a t i v e l y . Patient will also be assessed for incisional hernia formation at the same post-operative time points (1, 3, 6, 12 months). Hernia outcomes will be based on physical examination, with ultrasound used for any uncertainties. While surveillance imaging has been shown to be more sensitive for hernia detection, the primary purpose of this study is to compare the safety profile of Duramesh laparotomy closure to standard closure technique. Surveillance imaging for hernia identification is not a part of standard clinical practice at the participating study sites. The rate of clinically relevant hernias found on physical exam will be used to inform future efficacy studies, where routine surveillance imaging will be incorporated into the study design.
In addition to the patients undergoing primary laparotomy closure following an open trauma or emergency abdominal surgery, an additional subset of 20 patients undergoing delayed primary closure of an open abdomen will also be studied. These patients represent a particularly challenging clinical problem, for which there is no standard approach to repair. All 20 study patients undergoing delayed primary closure of an open abdomen will be closed with #1 or #2 Duramesh and followed according to the same post-operative protocol as those undergoing primary laparotomy closure. This subgroup is too small for randomization to provide useful data for comparison, and thus will be used to provide only a descriptive analysis of this early experience with delayed Duramesh closure of the open abdomen. The safety of Duramesh closure in this patient population can be extrapolated from the previously referenced experience of mesh strip closures in contaminated incisional hernias.
- Being tested
- Duramesh suturable mesh for laparotomy closure, Conventional suture for laparotomy closure
- Medical subject headings
- Incisional Hernia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Duramesh suturable mesh for laparotomy closureDevice
Patients undergoing laparotomy will be closed with Duramesh suturable mesh
Conventional suture for laparotomy closureDevice
Patients undergoing laparotomy will be closed with conventional polydiaxonone suture
| Study group | Role | What they receive |
|---|---|---|
| Duramesh suturable mesh for laparotomy closure | Experimental | Patients undergoing a midline laparotomy for trauma or emergency surgery will be closed with Duramesh suturable mesh. Receives: Device: Duramesh suturable mesh for laparotomy closure |
| Conventional suture closure for laparotomy closure | Experimental | Patients randomized to conventional laparotomy closure will be closed using size 1 slowly-absorbing polydiaxonone (PDS) single strand or looped suture, based on surgeon preference. Receives: Device: Conventional suture for laparotomy closure |
| Open abdomen group closed in delayed fashion with Duramesh | Experimental | Patients undergoing delayed primary closure of an open abdomen will also be studied. 20 study patients undergoing delayed primary closure of an open abdomen will be closed with Number 1 or Number 2 Duramesh Receives: Device: Duramesh suturable mesh for laparotomy closure |
What is being measured
The primary outcome is the main question the study is designed to answer.
Surgical site infection
Superficial or deep infection of the surgical site
Measured: 1 month
Surgical site infection
Superficial or deep infection of the surgical site
Measured: 3 months
Surgical site infection
Superficial or deep infection of the surgical site
Measured: 6 months
Surgical site infection
Superficial or deep infection of the surgical site
Measured: 12 months
Secondary outcomes (16)
Surgical site occurrence
Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
Measured: 1 month
Surgical site occurrence
Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
Measured: 3 months
Surgical site occurrence
Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
Measured: 6 months
Surgical site occurrence
Any complication related to the surgical site, including hematoma, seroma, dehiscence, fistula, small bowel obstruction, exposed suture, return to the operating room, readmission, or mortality
Measured: 12 months
Intraoperative and hospitalization endpoints
Details regarding abdominal wall closure
Measured: Within 30 days
Intraoperative and hospitalization endpoints
Length of hospital stay
Measured: Within 30 days
Intraoperative and hospitalization endpoints
Length of the laparotomy incision and length of suture remnant
Measured: Within 30 days
Intraoperative and hospitalization endpoints
Size of Duramesh used
Measured: Within 30 days
Hernia formation
Clinical development of an incisional hernia
Measured: anytime within 12 months
Patient reported outcomes
NRS pain scale
Measured: 3 months
Patient reported outcomes
NRS pain scale
Measured: 6 months
Patient reported outcomes
HerQles
Measured: 6 months
Patient reported outcomes
SF-36
Measured: 6 months
Patient reported outcomes
HerQles
Measured: 12 months
Patient reported outcomes
SF-36
Measured: 12 months
Patient reported outcomes
NRS pain scale
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 May 2019
- Study start15 Oct 2023 (estimated)
- Primary completion31 Dec 2024 (estimated)
- Study completion31 Dec 2025 (estimated)
Why it stopped: Mutual decision Walter Reed/U Maryland and Mesh Suture Inc.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for LaparotomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Clinical Trial
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mesh Suture Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, University of Maryland
- Responsible party
- Sponsor
- Investigators
- Jason M Souza, MD, Principal investigator, Walter Reed Army Institute of Research (WRAIR)Thomas Scalea, MD, Study director, U Maryland Shock Trauma
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03966768
- Sponsor's protocol ID
- 0001
- Status last verified
- Sep 2022
- First submitted
- 23 May 2019
- Last updated
- 13 Sep 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No: As per the sponsor wishes
Publications
Dumanian GA, Lanier ST, Souza JM, Young MW, Mlodinow AS, Boller AM, Mueller KH, Halverson AL, McGee MF, Stulberg JJ. Mesh sutured repairs of contaminated incisional hernias. Am J Surg. 2018 Aug;216(2):267-273. doi: 10.1016/j.amjsurg.2017.10.025. Epub 2017 Oct 25.
PubMed 29108644Lanier ST, Dumanian GA, Jordan SW, Miller KR, Ali NA, Stock SR. Mesh Sutured Repairs of Abdominal Wall Defects. Plast Reconstr Surg Glob Open. 2016 Sep 28;4(9):e1060. doi: 10.1097/GOX.0000000000001060. eCollection 2016 Sep.
PubMed 27757361Dumanian GA, Tulaimat A, Dumanian ZP. Experimental study of the characteristics of a novel mesh suture. Br J Surg. 2015 Sep;102(10):1285-92. doi: 10.1002/bjs.9853. Epub 2015 Jul 8.
PubMed 26154703Souza JM, Dumanian ZP, Gurjala AN, Dumanian GA. In vivo evaluation of a novel mesh suture design for abdominal wall closure. Plast Reconstr Surg. 2015 Feb;135(2):322e-330e. doi: 10.1097/PRS.0000000000000910.
PubMed 25626817
Study at a glance
From the registry record, last updated by the sponsor on 13 Sep 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- DuraMesh Laparotomy Closure Following Trauma and Emergency Surgery
- ClinicalTrials.gov ID
- NCT03966768
- Acronym / sponsor ID
- 0001
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Mutual decision Walter Reed/U Maryland and Mesh Suture Inc.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Mesh Suture Inc.Industry (pharma, biotech, devices)
- Collaborators
- Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, University of Maryland
- Study start
- 15 Oct 2023 (estimated)
- Primary completion
- 31 Dec 2024 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 29 May 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a multisite randomized control proof-of-concept trial to evaluate the safety of Duramesh laparotomy closure in the trauma and emergency laparotomy setting. The study will be performed at University of Maryland Shock Trauma Center and Walter Reed National Military Medical Center. One hundred (100) patients will be randomized (2:1) to Duramesh laparotomy closure versus conventional suture closure.
After the patient has been confirmed to be a candidate for the trial, randomization will be performed in the operating room upon completion of the index abdominal procedure. Duramesh will be provided for patients assigned to the Duramesh treatment arm. Patients will be followed for 1 year following laparotomy closure at follow-up intervals of 1 month, 3 months, 6 months, and 12 months.
Detailed description
Primary Laparotomy Closure Treatment 1) Study Group - Duramesh Laparotomy Closure (DLC) Treatment 2) Control Group - Conventional Suture Closure (CSC)
Patients undergoing a midline laparotomy for trauma or emergency surgery will have their abdominal wall laparotomy incision closed with size 0 Duramesh suturable mesh. Patients randomized to conventional laparotomy closure will be closed using size
1 slowly-absorbing (PDS) single strand or looped suture, based on surgeon preference.
While it would be preferable to identify a single conventional suture to serve as the control group, polling of potential participating surgeons demonstrated a preference for both single strand and looped sutures to be available for use in the conventional suture closure group. Both Duramesh and conventional sutures will be placed using a standardized closure technique that incorporates 1cm wide bites and 1cm spacing, as this is the established technique for trauma and emergency laparotomy closure at both participating institutions. An effort to quantify suture to wound length ratio will be made in an effort to confirm standardization of closure technique between groups. The small-bites surgical closure technique popular in Europe has not been adopted by trauma and emergency surgeons at either institution given concerns related to early dehiscence and the inability to extrapolate the STITCH trial data to a US trauma population. The surgeons at both institutions do not believe it acceptable to generalize the European trial with a mean BMI of 24 to the United States population, nor do they believe it wise to close the abdominal wall with a 2-0 polydioxanone suture, as this technique trended towards a higher rate of acute fascial dehiscence (burst abdomen).
All patients will be assessed for post-operative complications ( i . e . , infection, seroma, hematoma), a t 1 , 3 , 6 , and 12 months p o s t o p e r a t i v e l y . Patient will also be assessed for incisional hernia formation at the same post-operative time points (1, 3, 6, 12 months). Hernia outcomes will be based on physical examination, with ultrasound used for any uncertainties. While surveillance imaging has been shown to be more sensitive for hernia detection, the primary purpose of this study is to compare the safety profile of Duramesh laparotomy closure to standard closure technique. Surveillance imaging for hernia identification is not a part of standard clinical practice at the participating study sites. The rate of clinically relevant hernias found on physical exam will be used to inform future efficacy studies, where routine surveillance imaging will be incorporated into the study design.
In addition to the patients undergoing primary laparotomy closure following an open trauma or emergency abdominal surgery, an additional subset of 20 patients undergoing delayed primary closure of an open abdomen will also be studied. These patients represent a particularly challenging clinical problem, for which there is no standard approach to repair. All 20 study patients undergoing delayed primary closure of an open abdomen will be closed with #1 or #2 Duramesh and followed according to the same post-operative protocol as those undergoing primary laparotomy closure. This subgroup is too small for randomization to provide useful data for comparison, and thus will be used to provide only a descriptive analysis of this early experience with delayed Duramesh closure of the open abdomen. The safety of Duramesh closure in this patient population can be extrapolated from the previously referenced experience of mesh strip closures in contaminated incisional hernias.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
- Model description
- Randomized Clinical Trial
| Arm | Type | Receives |
|---|---|---|
| Duramesh suturable mesh for laparotomy closure | Experimental | Device: Duramesh suturable mesh for laparotomy closurePatients undergoing a midline laparotomy for trauma or emergency surgery will be closed with Duramesh suturable mesh. |
| Conventional suture closure for laparotomy closure | Experimental | Device: Conventional suture for laparotomy closurePatients randomized to conventional laparotomy closure will be closed using size 1 slowly-absorbing polydiaxonone (PDS) single strand or looped suture, based on surgeon preference. |
| Open abdomen group closed in delayed fashion with Duramesh | Experimental | Device: Duramesh suturable mesh for laparotomy closurePatients undergoing delayed primary closure of an open abdomen will also be studied. 20 study patients undergoing delayed primary closure of an open abdomen will be closed with Number 1 or Number 2 Duramesh |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Midline laparotomy greater than 5 cm in length
- Urgent or emergent surgery following trauma
- Urgent or emergent surgery for diverticulitis
- Large or small bowel obstruction, acute abdomen, or intra-abdominal hemorrhage.
- Open abdomen after midline laparotomy.
Key exclusion criteria (4 listed)
- Prior hernia repair or existing abdominal mesh
- Metastatic cancer
- Pregnancy
- Immunosuppression.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Duramesh suturable mesh for laparotomy closurePatients undergoing laparotomy will be closed with Duramesh suturable mesh | Device | Duramesh suturable mesh for laparotomy closure, Open abdomen group closed in delayed fashion with Duramesh |
| Conventional suture for laparotomy closurePatients undergoing laparotomy will be closed with conventional polydiaxonone suture | Device | Conventional suture closure for laparotomy closure |
Primary outcome
Surgical site infection
Time frame: 1 month
Superficial or deep infection of the surgical site
Surgical site infection
Time frame: 3 months
Superficial or deep infection of the surgical site
Surgical site infection
Time frame: 6 months
Superficial or deep infection of the surgical site
Surgical site infection
Time frame: 12 months
Superficial or deep infection of the surgical site
16 secondary outcomes
Surgical site occurrence
Time frame: 1 month
Surgical site occurrence
Time frame: 3 months
Surgical site occurrence
Time frame: 6 months
Surgical site occurrence
Time frame: 12 months
Intraoperative and hospitalization endpoints
Time frame: Within 30 days
Intraoperative and hospitalization endpoints
Time frame: Within 30 days
Intraoperative and hospitalization endpoints
Time frame: Within 30 days
Intraoperative and hospitalization endpoints
Time frame: Within 30 days
Hernia formation
Time frame: anytime within 12 months
Patient reported outcomes
Time frame: 3 months
Patient reported outcomes
Time frame: 6 months
Patient reported outcomes
Time frame: 6 months
Patient reported outcomes
Time frame: 6 months
Patient reported outcomes
Time frame: 12 months
Patient reported outcomes
Time frame: 12 months
Patient reported outcomes
Time frame: 12 months
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Sep 2022.
- Background: PubMed 29108644Dumanian GA, Lanier ST, Souza JM, Young MW, Mlodinow AS, Boller AM, Mueller KH, Halverson AL, McGee MF, Stulberg JJ. Mesh sutured repairs of contaminated incisional hernias. Am J Surg. 2018 Aug;216(2):267-273. doi: 10.1016/j.amjsurg.2017.10.025. Epub 2017 Oct 25.
- Background: PubMed 27757361Lanier ST, Dumanian GA, Jordan SW, Miller KR, Ali NA, Stock SR. Mesh Sutured Repairs of Abdominal Wall Defects. Plast Reconstr Surg Glob Open. 2016 Sep 28;4(9):e1060. doi: 10.1097/GOX.0000000000001060. eCollection 2016 Sep.
- Background: PubMed 26154703Dumanian GA, Tulaimat A, Dumanian ZP. Experimental study of the characteristics of a novel mesh suture. Br J Surg. 2015 Sep;102(10):1285-92. doi: 10.1002/bjs.9853. Epub 2015 Jul 8.
- Background: PubMed 25626817Souza JM, Dumanian ZP, Gurjala AN, Dumanian GA. In vivo evaluation of a novel mesh suture design for abdominal wall closure. Plast Reconstr Surg. 2015 Feb;135(2):322e-330e. doi: 10.1097/PRS.0000000000000910.
- Individual participant dataSharing planned: No. As per the sponsor wishes
Related trials for Laparotomy
Not yet recruitingObservational study
Intra-Abdominal Pressure, Respiratory Mechanics, and Ventilator Liberation After Emergency Major Laparotomy
Intra-Abdominal Hypertension, Respiratory Mechanics
Recruiting
Effect of Opioid-sparing Anesthesia on Quality of Recovery After Emergency Laparotomy
Emergency Abdominal Surgery, Opioid Sparing Anaesthesia
Active, not recruitingPhase 4
Early vs Postponed Parenteral Nutrition After Emergency Abdominal Surgery
Laparotomy, Bowel Obstruction
Active, not recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Open Midline Laparotomy
Recruiting
Skin Staples vs Polypropylene in Elective Laparotomy
Surgical Site Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jason M Souza, MD principal investigator
Walter Reed Army Institute of Research (WRAIR)
Thomas Scalea, MD study director
U Maryland Shock Trauma
Questions about this trial
What is this clinical trial studying?
A study testing Duramesh suturable mesh for laparotomy closure and Conventional suture for laparotomy closure in people with Laparotomy and Suture; Complications, Mechanical, run by Mesh Suture Inc..
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 13 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Surgical site infection (time frame: 1 month). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03966768, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2022.